The Paradoxes of Neoantigenes in Predicting Better Prognosis of Cancer Patients
Journal Title: Global Journal of Cancer Therapy - Year 2016, Vol 2, Issue 1
Abstract
Increased neoantigens of cancer generated by mutations are reported to be associated with favorable prognosis of cancer patients. The interesting findings contradict the notions that cancers were caused by accumulation of gene mutations. The explanation of more efficient immunosurveillance provoked by the neoantigens contributes to the better outcomes also contradicts many more facts, i.e., the immunosurveillance in nature is inflammation which is a term of pathologist. The cancer related inflammation is widely accepted as a cancer promoting fact; more efficient immunosurveillance would result in more apoptosis of cancer cells. However, increased apoptosis were known to be associated with worse prognosis. Moreover, increasing evidence has shown that the expression of immune suppressing genes such as PD-1, PD-L1 and CTLA-4 were associated with better prognosis of cancer patients.
Authors and Affiliations
Wang Rui-An, Yan Qing-Guo, Shi Jian-Guo
Keywords
Related Articles
- EP ID EP352867
- DOI 10.17352/2581-5407.000011
- Views 119
- Downloads 0
The Role of Decavanadate in Anti-Tumour Activity
Decavanadate compounds were described to be involved in a variety of biological activities and responses such as anti-virus, anti-bacterial and anticancer. While the mechanisms of action of the anti-viral and anti-bacter...
Primary Spindle Cell Rhabdomyosarcoma of Prostate: A Case Report with Review of Literature
Primary spindle cell rhabdomyosarcoma of the prostate is an uncommon variant of embryonal rhabdomyosarcoma seen in pediatric age group mostly during infancy and childhood. Rhabdomyosarcoma (RMS) arising from prostate pre...
Is it Time for the Introduction of Colostomy Free Survival in Rectal Cancer Patients
The rectum is considered the straight part of the bowel although it’s not straight with at least three folds. Sometimes defined as the last 12 cm of the large bowel other consider it as the last 15 cm. Surgeons mark it s...
Angiosarcoma of the Scalp and Face: A Hard to Treat Tumor
Cutaneous angiosarcoma is a rare and aggressive malignant tumor of vascular origin. Multimodality treatment including surgery, radiotherapy and chemotherapy should be used according to age and local spread. Prognosis is...
Lenvatinib Suppresses Angiogenesis through the Inhibition of both the VEGFR and FGFR Signaling Pathways
Lenvatinib mesilate (lenvatinib) is an oral multiple-receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of Vascular Endothelial Growth Factor Receptor (VEGFR) 1-3, Fibroblast Growth Fact...